Francesco De Chiara
Rowland Hill Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A 3D bioengineered human liver for the study of acute and chronic drug-induced hepatotoxicity and fibrosis.
Journal: Frontiers in bioengineering and biotechnology
Published: January 29, 2026
Progressive impairment of bioengineered skeletal muscles by MASLD-derived factors: a platform to model liver-induced muscle wasting.
Journal: Disease models & mechanisms
Published: January 13, 2026
ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity.
Journal: Molecular therapy. Nucleic acids
Published: October 30, 2025
The Tissue Engineering Revolution: From Bench Research to Clinical Reality.
Journal: Biomedicines
Published: January 26, 2024
Role of ammonia in NAFLD: An unusual suspect.
Journal: JHEP reports : innovation in hepatology
Published: November 08, 2022
Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver.
Journal: Biomedicines
Published: March 25, 2022
Ammonium quantification in human plasma by proton nuclear magnetic resonance for staging of liver fibrosis in alcohol-related liver disease and nonalcoholic fatty liver disease.
Journal: NMR in biomedicine
Published: March 03, 2022
Collagen-Tannic Acid Spheroids for β-Cell Encapsulation Fabricated Using a 3D Bioprinter.
Journal: Advanced materials technologies
Published: December 21, 2021
Disposable Polymeric Nanostructured Plasmonic Biosensors for Cell Culture Adhesion Monitoring.
Journal: Frontiers in bioengineering and biotechnology
Published: October 21, 2021
The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research.
Journal: Biomedicines
Published: January 29, 2021
Direct and Label-Free Monitoring of Albumin in 2D Fatty Liver Disease Model Using Plasmonic Nanogratings.
Journal: Nanomaterials (Basel, Switzerland)
Published: November 18, 2020
Last Updated: 09/26/2026